Notice2024-09382
Statement of Organization, Functions, and Delegations of Authority
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 7, 2024
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration's (FDA), Center for Devices and Radiological Health's (CDRH), Office of Product Evaluation and Quality (OPEQ) has modified their organizational structure. The new organizational structure was approved by the Secretary of Health and Human Services on December 21, 2023, and it became effective on January 22, 2024.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 89 (Tuesday, May 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 89 (Tuesday, May 7, 2024)]
[Notices]
[Page 38158]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-09382]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration's (FDA), Center for Devices
and Radiological Health's (CDRH), Office of Product Evaluation and
Quality (OPEQ) has modified their organizational structure. The new
organizational structure was approved by the Secretary of Health and
Human Services on December 21, 2023, and it became effective on January
22, 2024.
FOR FURTHER INFORMATION CONTACT: Yashika Rahaman, Director, Office of
Planning, Evaluation and Risk Management, Office of Finance, Budget,
Acquisitions and Planning, Food and Drug Administration, 4041 Powder
Mill Rd., Beltsville, MD 20705-4304, 301-796-3843.
I. Introduction
Part D, Chapter D-B, (Food and Drug Administration), the Statement
of Organization, Functions and Delegations of Authority for the
Department of Health and Human Services (35 FR 3685, February 25, 1970,
60 FR 56606, November 9, 1995, 64 FR 36361, July 6, 1999, 72 FR 50112,
August 30, 2007, 74 FR 41713, August 18, 2009, 76 FR 45270, July 28,
2011, and 84 FR 22854, May 20, 2019) is amended to reflect the
reorganization of the CDRH OCE.
The reorganization of OPEQ impacted the OPEQ's Office of Clinical
Evidence and Analysis (OCEA) and the OPEQ's Office of Health Technology
IV (OHT IV). OCEA established the Division of Clinical Evidence and
Analysis IV and the Division of Clinical Evidence and Analysis V. OHT
IV established the Division of Health Technology IV C.
DCCFB. ORGANIZATION. CDRH's OPEQ OCEA is headed by the Director,
and includes the following:
Office of Clinical Evidence and Analysis (DCCFB)
Division of Clinical Evidence and Analysis I (DCCFBA)
Division of Clinical Evidence and Analysis II (DCCFBB)
Division of Clinical Evidence and Analysis III (DCCFBC)
Division of Clinical Evidence and Analysis IV (DCCFBD)
Division of Clinical Evidence and Analysis V (DCCFBE)
DCCFF. ORGANIZATION. CDRH's OPEQ OHT IV is headed by the Director,
and includes the following:
Office of Health Technology IV (DCCFF)
Division of Health Technology IV A (DCCFFA)
Division of Health Technology IV B (DCCFFB)
Division of Health Technology IV C (DCCFFC)
II. Delegations of Authority
Pending further delegation, directives, or orders by the
Commissioner of Food and Drugs, all delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegations, provided they are consistent with this reorganization.
III. Electronic Access
This reorganization is reflected in FDA's Staff Manual Guide (SMG).
Persons interested in seeing the complete SMG can find it on FDA's
website at: <a href="https://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/default.htm">https://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/default.htm</a>.
(Authority: 44 U.S.C. 3101).
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2024-09382 Filed 5-6-24; 8:45 am]
BILLING CODE 4164-01-P
</pre></body>
</html>Indexed from Federal Register on May 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.